Wolverine Trading’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$94.1K Buy
3,392
+104
+3% +$3.93K ﹤0.01% 5222
2025
Q2
$190K Buy
+3,288
New +$264K ﹤0.01% 3941
2025
Q1
Sell
-1,804
Closed -$86.1K 4662
2024
Q4
$86.1K Sell
1,804
-184
-9% -$11.1K ﹤0.01% 4845
2024
Q3
$186K Buy
1,988
+48
+2% +$6.2K ﹤0.01% 4140
2024
Q2
$317K Buy
1,940
+572
+42% +$81.5K ﹤0.01% 3323
2024
Q1
$209K Buy
1,368
+780
+133% +$130K ﹤0.01% 3767
2023
Q4
$184K Sell
588
-300
-34% -$109K ﹤0.01% 3912
2023
Q3
$394K Buy
888
+196
+28% +$88.5K ﹤0.01% 3002
2023
Q2
$297K Buy
+692
New +$389K ﹤0.01% 3104
2023
Q1
Sell
-4,276
Closed -$1.73M 4145
2022
Q4
$1.73M Buy
+4,276
New +$2.01M ﹤0.01% 1481
2022
Q3
Sell
-1,684
Closed -$895K 4507
2022
Q2
$895K Sell
1,684
-2,028
-55% -$1.03M ﹤0.01% 2023
2022
Q1
$2.3M Buy
+3,712
New +$1.91M ﹤0.01% 1640
2021
Q4
Sell
-316
Closed -$207K 5634
2021
Q3
$207K Buy
+316
New +$270K ﹤0.01% 5285

Other funds holding AGL

Wolverine Trading's AGL Position: Q3 2025 in Review

Wolverine Trading increased its Agilon Health (AGL) stake by 203% in Q3 2025, buying an estimated $33K and bringing the position to 1,304 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Wolverine Trading first reported a position in AGL in Q1 2022 and has held it in 4 quarters since. The position peaked at $216K in Q1 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Wolverine Trading held 1,304 shares of Agilon Health worth $36.2K as of Q3 2025.
  • Wolverine Trading bought 874 Agilon Health shares in Q3 2025, an estimated $33K.
  • Agilon Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5481 holding.
  • Wolverine Trading first reported a position in Agilon Health in Q1 2022 and has held it in 4 quarters since.
  • Wolverine Trading's Agilon Health position peaked at $216K in Q1 2022.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.